SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-022309
Filing Date
2019-11-12
Accepted
2019-11-12 08:19:30
Documents
3
Period of Report
2019-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20191108_8k.htm 8-K 24133
2 EXHIBIT 99.1 ex_164000.htm EX-99.1 115395
3 ex_164000img001.jpg GRAPHIC 4079
  Complete submission text file 0001437749-19-022309.txt   146719
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 191206323
SIC: 2834 Pharmaceutical Preparations